Repligen | RGEN - Ebit





Ebit Veränderung Datum
Agilent USD 444M 45M 2026-06
Align Technology USD 193.04M 1.72M 2026-09
Bio Techne USD 75.49M 21.03M 2026-03
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Bruker USD 69.6M 59.4M 2026-06
Charles River Laboratories USD 119.89M 9K 2026-06
Danaher USD 1.25B 118M 2026-09
Dentsply International USD 84M 52M 2026-06
General Electric Aerospace USD 2.22B 123M 2026-09
Henry Schein USD 200M 6M 2026-06
Illumina USD 260M 21M 2026-06
IQVIA Holdings USD 608M 1.99B 2026-09
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Pfizer USD -180M 5.16B 2026-06
Repligen USD 24.31M 3.18M 2026-09
Revvity USD 126.14M 43.36M 2026-06
Standard Biotools USD -9.42M 12.51M 2026-03
Thermo Fisher Scientific USD 2.46B 277M 2026-09
Waters USD 10M 138M 2026-06
West Pharmaceutical Services USD 179.1M 2M 2026-06